Streck will present and exhibit at the upcoming Molecular Medicine Tri-Conference held in San Francisco, CA, Feb. 20-23, 2017.
Michael van Waes, Ph.D., the Director of Molecular Products at Streck, will give a presentation titled “20-Minute Detection of Antibiotic Resistance Genes in Clinical Isolates” on Tuesday, Feb. 21 from
3:40-3:55 p.m. in the Molecular Diagnostics for Infectious Disease track. His presentation explains how rapid testing strategies characterize antibiotic resistant organisms and improve laboratory workflow. The Streck Zulu RT™ Real-Time PCR System, in combination with the Streck ARM-D® Real-Time PCR Kits, can screen samples for the presence of genes that mediate resistance in 20 minutes. Dr. van Waes has 17 years of experience in the development and commercialization of instrumentation in the Life Sciences industry and is currently exploring rapid PCR-based diagnostic tests for clinical and research laboratories.
Landon Olp, Ph.D., an R&D Scientist at Streck, will give a presentation featuring Cell-Free DNA BCT® on Thursday, Feb. 23 from 3-3:15 p.m. in the Circulating Cell-Free DNA track. His presentation explains how the Cell-Free DNA BCT stabilizes nucleated blood cells up to 14 days, improving sample collection/transport logistics while minimizing variability of cfDNA preparation.
Dr. Olp will also present poster #91 addressing how the Cell-Free DNA BCT is compatible with biosulfite conversion and methylation-specific qPCR in the Epi proColon Assay. Dr. Olp received his Ph.D. in Biological Sciences from the University of Nebraska-Lincoln with a molecular biology specialization.
Dr. Olp works in Streck’s immunology and biomarkers division and has focused on Streck’s blood collection tubes, including Cell-Free DNA BCT and Cell-Free RNA BCT.
TRI-CON focuses on discovery, genomics, diagnostics and information technology in molecular medicine and attracts over 3,500 professionals from over 40 countries. Visit Streck at booth #2. Find more information about the conference at www.streck.com.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.